Trade Vir Biotechnology ^VIR

Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data

Vir Biotechnology Shares Jump Over 50% After Positive Phase 1 VIR-5500 Prostate Cancer Data

Vir Biotechnology Inc (VIR) Q4 2025 Earnings Call Highlights: Strategic Collaborations and ...

Vir Biotechnology (NASDAQ:VIR) Releases Earnings Results, Beats Expectations By $0.11 EPS

Vir Biotechnology Q4 Earnings Call Highlights - Stock Observer

Japan's Astellas announces $1.37 B deal with Vir Biotechnology to develop T-Cell therapies for prostate cancer

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results | Morningstar

Astellas and Vir Biotechnology Announce Global Strategic Col

Astellas collaborates with Vir to develop its experimental prostate cancer drug

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer | Morningstar

Vir Biotechnology (NASDAQ:VIR) CAO Sells $11,918.70 in Stock

Aberdeen Group plc Purchases 519,374 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology (NASDAQ:VIR) CAO Brent Sabatini Sells 1,530 Shares

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts

Vir Biotechnology (VIR) Projected to Post Earnings on Monday

Needham & Company LLC Reiterates Buy Rating for Vir Biotechnology (NASDAQ:VIR) - Markets Daily

Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham & Company LLC - Stock Observer

Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares

Did Vir's Advancing Hepatitis D Combo Program Just Shift Vir Biotechnology's (VIR) Investment Narrative? - Simply Wall St News

Chronic Hepatitis D Market Poised for Significant Growth During the Forecast Period (2025-2034) as Emerging Therapies Drive Optimism | DelveInsight

Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed?

3 Vanguard ETFs to watch in 2026: VTV ETF, MGV ETF, VOO ETF

NVIDIA (NVDA) Stock Price & Overview 2026: What is Nvidia stock prediction?

Bitcoin slips under $63K: Will BTC price keep going down in 2026?

Novo Nordisk (NVO) stock analysis: Novo shares drop 16%, what’s next for NVO?

Commodity market today: gold (XAU/USD) and sliver dropped, what’s next?

Crude oil forecast today: Are WTI and Brent expected to rise in 2026?

Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?

Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?

Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?

Gold price forecast: XAU/USD remains under $5000, what’s next?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift